中国药业
中國藥業
중국약업
CHINA PHARMACEUTICALS
2014年
19期
21-21,22
,共2页
王林丽%李卓恒%吕金胜%卢来春
王林麗%李卓恆%呂金勝%盧來春
왕림려%리탁항%려금성%로래춘
益精灵口服液%SD大鼠%长期毒性
益精靈口服液%SD大鼠%長期毒性
익정령구복액%SD대서%장기독성
Yijingling Oral Liquid%rats%safety test
目的:考察益精灵口服液长期给药对大鼠的影响,为临床安全用药提供科学参考依据。方法将大鼠随机分为对照组及低[0.5 mL/(kg·d)]、中[2.5 mL/(kg·d)]、高[5 mL/(kg·d)]剂量组,给药量分别相当于临床患者每日用量的1,5,10倍。30 d后每组随机处死雌雄大鼠各5只,取尾静脉血进行血常规检查和血液生化指标,以及心、肝、肾、肺作组织病理学检查。结果连续给药30 d后,各剂量组动物的体重、血液生化指标、血常规未发生变化,心、肝、肾、肺均未见有明显的病理改变。结论益精灵口服液临床用药较安全。
目的:攷察益精靈口服液長期給藥對大鼠的影響,為臨床安全用藥提供科學參攷依據。方法將大鼠隨機分為對照組及低[0.5 mL/(kg·d)]、中[2.5 mL/(kg·d)]、高[5 mL/(kg·d)]劑量組,給藥量分彆相噹于臨床患者每日用量的1,5,10倍。30 d後每組隨機處死雌雄大鼠各5隻,取尾靜脈血進行血常規檢查和血液生化指標,以及心、肝、腎、肺作組織病理學檢查。結果連續給藥30 d後,各劑量組動物的體重、血液生化指標、血常規未髮生變化,心、肝、腎、肺均未見有明顯的病理改變。結論益精靈口服液臨床用藥較安全。
목적:고찰익정령구복액장기급약대대서적영향,위림상안전용약제공과학삼고의거。방법장대서수궤분위대조조급저[0.5 mL/(kg·d)]、중[2.5 mL/(kg·d)]、고[5 mL/(kg·d)]제량조,급약량분별상당우림상환자매일용량적1,5,10배。30 d후매조수궤처사자웅대서각5지,취미정맥혈진행혈상규검사화혈액생화지표,이급심、간、신、폐작조직병이학검사。결과련속급약30 d후,각제량조동물적체중、혈액생화지표、혈상규미발생변화,심、간、신、폐균미견유명현적병리개변。결론익정령구복액림상용약교안전。
Objective To investigate the influence of long term administration of Yijinging Oral Liquid on rats so as to provide the scientific basis for its clinical safe use. Methods Rats were divided into four groups and administrated by oral saline, 0. 5 mL/(kg·d), 2. 5 mL/ (kg·d), 5 mL/ (kg·d) of Yijingling Oral Liquid respectively, which equivalent to 1, 5, 10 times of daily dose in clinical patients. All the rates were executed after 30 d, and the blood routine examination ( Hb, WBC, RBC ) , blood biochemical index ( AST, ALT, T-BIL ) and histopathological examination ( heart, liver, lung and kidney ) were performed. Results After 30 d,No changes were found neither in the body weight, blood routine examination and blood biochemical index, nor in the histopathological examination of heart, kidney and liver in the various doses groups. Conclusion Yijingling Oral Liquid can be safely used in clinic.